Xenon Pharmaceuticals Inc (NASDAQ:XENE) Receives Average Recommendation of Buy from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Silverarc Capital Management LLC decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 45.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 53,996 shares of the biopharmaceutical company’s stock after selling 45,760 shares during the quarter. Silverarc Capital Management LLC owned […]
Xenon Pharmaceuticals (NASDAQ:XENE – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $54.00 to $59.00 in a report published on Tuesday morning, BayStreet.CA reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other research firms also recently weighed in on XENE. Stifel Nicolaus […]
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) have received an average recommendation of “Buy” from the twelve research firms that are presently covering the firm, Marketbeat Ratings reports. Eleven investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 […]
Royal Bank of Canada restated their outperform rating on shares of Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) in a report issued on Wednesday, Benzinga reports. The brokerage currently has a $51.00 price target on the biopharmaceutical company’s stock. Other equities research analysts have also recently issued reports about the company. The Goldman Sachs Group assumed […]